Neurelis Takes Part in Epilepsy Awareness Day at Walt Disney World to Promote Education and Support

Neurelis Supports Epilepsy Awareness at Disney World

Neurelis, Inc., the company behind the innovative epilepsy treatment VALTOCO® (diazepam nasal spray), is excited to announce its participation in the inaugural Epilepsy Awareness Day and Education Expo at Walt Disney World. Set to take place on April 25-26, 2026, this event represents a significant milestone in raising awareness and providing essential support to the epilepsy community, including patients, caregivers, and healthcare professionals.

Organized in collaboration with the Epilepsy Association of Florida, Epilepsy Alliance America (EAA), and Sophie's Journey, the event aims to foster a national network dedicated to epilepsy awareness, interactive learning, and community support.

Event Details

The free education expo will occur at Disney's Contemporary Resort, running from 9 AM to 5 PM PT. Attendees will have access to a variety of presentations and discussions aimed at enhancing understanding of epilepsy management and treatment options. Following the expo, families will celebrate together at a special party in the evening, culminating in an exciting Epilepsy Awareness Day at Magic Kingdom on April 26.

Lowell, a Neurelis Ambassador living with epilepsy, expressed enthusiasm about representing Neurelis at this impactful event.